Interim report January – March 2026

The group reported Q1 2026 net sales of 3,374, down from 4,574 a year earlier, while operating result remained deeply negative at -22,228 versus -13,537. Result after financial items was -21,724, and cash flow from operating activities stayed negative at -11,610. The figures point to continued operational weakness and persistent cash burn, though the update is mainly a historical performance summary rather than a new catalyst.

Analysis

The key takeaway is not just weak operating performance, but the compounding effect of negative operating leverage: revenue shortfall is being amplified into a disproportionately larger earnings and cash burn problem. That usually means the business has crossed from cyclical weakness into structural fragility, where incremental sales no longer translate into margin recovery unless fixed-cost absorption improves quickly. In this setup, every quarter of delay increases the odds of punitive refinancing, equity dilution, or forced asset sales.

The second-order loser is the company’s supplier and creditor ecosystem. As liquidity tightens, management typically stretches payables, cuts capex, and delays discretionary spend, which can transmit stress to smaller vendors first and then to logistics/industrial counterparties with exposure to the same end market. Competitors with cleaner balance sheets should see share gains as the weaker player loses pricing power and optionality; the market often underestimates how quickly a cash-burning operator can become a share donor in a soft-demand environment.

Catalyst risk is asymmetric over the next 1-3 quarters: absent a sharp demand recovery or a credible cost-reset, the market will likely refocus from earnings to solvency. The real inflection to watch is not headline sales, but whether operating cash burn is narrowing; if not, the equity becomes a residual claim on shrinking enterprise value. A reversal would require either an external funding solution or a step-change in gross margin that is unlikely to arrive organically without a broader sector re-rating.

The contrarian angle is that the selloff may still be underestimating dilution risk rather than overpricing it. In distressed operating profiles, equity holders often anchor on normalized earnings, but the market usually prices the next capital action first. If there is any rally, it is more likely to be technical than fundamental unless management can demonstrate a credible break-even path within two reporting cycles.

Key Decisions for Investors

• Avoid long exposure for the next 1-2 quarters; if held, trim on any liquidity-driven bounce rather than waiting for a fundamental turn.
• If liquid, initiate a short on the equity or a put spread 2-4 months out to express the view that the next catalyst is financing risk, not earnings recovery.
• Pair trade: long a higher-quality competitor with stronger free-cash-flow conversion versus this name to isolate market share transfer and balance-sheet dispersion.
• Require proof of operating cash burn improvement before reconsidering long exposure; a single quarter of better sales is not enough if cash outflow persists.
• If the company has debt trading, prefer capital structure shorts via CDS or subordinated debt over common equity for better risk/reward into a possible restructuring timeline.